Cuu Long Pharmaceutical JSC (HOSE:DCL)

Vietnam flag Vietnam · Delayed Price · Currency is VND
27,350
-550 (-1.97%)
At close: Jun 5, 2025
-7.91%
Market Cap 1.99T
Revenue (ttm) 1.37T
Net Income (ttm) 56.44B
Shares Out 73.04M
EPS (ttm) 772.32
PE Ratio 35.35
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 251,611
Average Volume 547,528
Open 27,850
Previous Close 27,900
Day's Range 27,100 - 27,850
52-Week Range 19,000 - 32,000
Beta 0.55
RSI 67.63
Earnings Date Jul 30, 2025

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicine primarily in Vietnam. The company offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. It sells its products to hospitals, pharmacies, and drugstores. Additionally, the company is involved in the trading pharmaceuticals and medical equipment, and producing medicine,... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 885
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DCL
Full Company Profile

Financial Performance

In 2024, HOSE:DCL's revenue was 1.31 trillion, an increase of 14.24% compared to the previous year's 1.14 trillion. Earnings were 53.57 billion, a decrease of -10.29%.

Financial Statements

News

There is no news available yet.